ASML · ASML Holding N.V.

Current Thesis

The EUV-monopoly story remains the cleanest second-derivative on the AI-capex super-cycle, and the narrative is still pulling forward rather than rolling over. CEO Christophe Fouquet reframed chips as a "supply-limited market for quite a while" with "sporadic bottlenecks" (2026-05-20) demand-visibility language with multi-quarter reach, not cycle-top talk. High-NA is set to show first product data on both logic and DRAM "later this year" (2026-05-20), widening the monopoly TAM into memory and layering an advanced-packaging tool adjacency onto the EUV core. Sell-side keeps climbing the wall: JP Morgan Overweight with PT raised to $2,200 (2026-06-03), above RBC's $1,700 (2026-04-16). So the theme reads ACCELERATING but the entry is MATURING and crowded: +41% YTD into the 2026-04-15 beat-and-raise, extended above the 20/50-DMA, and heading into a Q2 print (~2026-07-16) that guides sequentially down 13–18%. The picks-and-shovels discipline says buy the pullback with volume, not the vertical leg into a guide-down quarter.

Bull Case

• CEO "supply-limited market for quite a while" (2026-05-20): explicit multi-quarter demand-visibility framing with "sporadic bottlenecks"; Fouquet cited a chip-supply conversation with Elon Musk narrative pulling forward.
• High-NA on logic AND DRAM later in 2026 + new packaging tool (2026-05-20): extends the monopoly into memory and adds CoWoS-style advanced-packaging optionality on top of the EUV franchise.
• JPM Overweight, PT $2,200 (2026-06-03): targets still rising two months post-print (RBC $1,700 on 2026-04-16 → JPM $2,200), so upgrade velocity is intact rather than exhausted.
• FY2026 guide €36B–€40B, raised at Q1 (2026-04-15): built on TSMC capex +32% YoY (~$55B) and hyperscaler 2nm pull-in; TSM is ~40% of ASML revenue, so the flow-through is direct.
• Smart-money Q1 13F builds (2026-05-15): Third Point new 12,000-sh stake and Appaloosa new 49,500-sh stake, even as Loeb cut NVDA/MSFT (2026-05-18) discretionary funds adding the leading-edge tool name.
• China chip exports doubled to $31B in April (2026-05-22): confirms AI-silicon end-demand is real and supply-tight, supporting global leading-edge tool pull.
• Management called 2027 a "growth year" at Q1 (2026-04-15) despite near-term softness framing the Q2 dip as shipment timing rather than demand destruction.
• Musk "Terafab" chip moonshot pitch reportedly at ASML (2026-06-05): incremental greenfield-fab narrative; any new leading-edge fab is an EUV customer.

Bear Case

• Q2 guide €8.4B–€9.0B = sequential −13% to −18% (2026-04-15): lumpy shipment cadence into a headline-risk print ~2026-07-16; a crowded long into a soft sequential number is the classic fade setup.
• Nikon CEO vows low-priced challenge (2026-05-28): aimed at DUV/low-end and at diversifying from Intel reliance; it does not touch EUV, so the leading-edge monopoly is intact, but it is a fresh competitive headline that can chip at the "uncontested sole-source" frame if it gains traction.
• China domestic-substitution accelerating (2026-05-22): US restrictions explicitly "fuel Beijing's push toward domestic chip production"; ~15% of revenue is China-exposed slow structural TAM erosion masked by the AI-demand noise.
• Macro repricing (2026-05-15): CME FedWatch ~56% odds of a Fed hike by Dec 2026; "the bond market fired a warning shot at the AI rally." High-multiple semicap derates first if rates back up.
• Crowding + extension: +41% YTD into the April print with no pullback-and-volume reset; an entry on the vertical leg carries mean-reversion risk into a quarter that prints down sequentially.

Setup & Price Structure

• Trend is intact and extended: price sits above the rising 20/50-DMA after +41% YTD into the 2026-04-15 beat-and-raise; momentum is top-quartile and RSI read a healthy ~62 in mid-May (not yet overbought).
• Entry discipline (picks-and-shovels): the clean add is a 20/50-DMA pullback with volume absorption (RVOL>1.5). That confirmation has not printed RVOL last read ~1.0–1.19x in mid-May, i.e. drift higher on average volume, no accumulation thrust.
• The sell-side ladder doubles as a resistance/target map: RBC $1,700 (4/16) → JPM $2,200 (6/3). Price has been climbing that upgrade wall, which confirms velocity but also signals the early-narrative window has closed.
• No recent base to lean on; the asymmetric entry is a controlled pullback toward the 20-week EMA, while chasing the current extension into the Q2 print is the low-edge action.

Catalyst Calendar (next 30 days)

• ~2026-06 → ongoing: High-NA first product-data readouts on logic/DRAM flagged for "later this year" (2026-05-20) no fixed date; watch for any pre-Q2 disclosure.
• 2026-06-05 (in motion): Musk "Terafab" pitch reportedly delivered at ASML track for any follow-through on a greenfield leading-edge fab commitment.
• ~2026-07-13 (est.): pre-print de-risk / blackout window ahead of Q2.
• 2026-07-16 (est., OUTSIDE the 30-day window): Q2 2026 earnings the next hard binary; the guide is the lumpy sequential step-down (−13% to −18%). This is the print to flatten exposure into, not chase.
• No FDA/PDUFA, index reconstitution, or other hard dated event inside the next 30 days.

What Would Change Our Mind

• Bullish confirmation (upgrade trigger): a 20/50-DMA pullback that holds with RVOL>1.5 absorption supplies the missing entry signal and flips the read from WATCH to actionable.
• Structural invalidation: a weekly close below the rising 20-week EMA fires the scale-out (50%), independent of RSI.
• Fundamental break: Q2 revenue below the €8.4B guide floor, or any FY2026 cut below €36B at the ~2026-07-16 print a genuine demand break beyond shipment timing.
• Competitive break: evidence that Nikon, Canon, or a Chinese domestic tool takes EUV-class (leading-edge) share DUV wins do not count would erode the monopoly premium.
• Theme flip: ai-chip-infra-memory rolling from ACCELERATING to SATURATED (CNBC-mainstream peak retail, cluster peers failing to make new highs) is the stand-down cue.

Correlation Notes

• ASML correlates >0.7 with the leading-edge logic/semicap cluster TSM, AMAT, KLA, LRCX and with NVDA as the underlying demand engine. It is the quality expression of the EUV thesis, but concurrent exposure to TSM + ASML + AMAT is one bet, not three; treat any leading-edge semicap position as shared theme risk and avoid stacking the cluster beyond a single full-thesis unit.
• TSM is ~40% of ASML revenue, so TSMC capex revisions and High-NA adoption timing move ASML directly the 2026-04-24 TSMC High-NA timing snub produced a ~−$16B ASML reaction.
• A second-order memory link runs through High-NA-into-DRAM; a memory up-cycle (Micron near 52-week highs, constrained supply cited through 2028, 2026-05-14) is an indirect tailwind.
• Liquidity note: the US ADR is tradable on a US exchange, but quote width can widen on low-volume sessions size and execution should account for it.